Melanoma Program

Melanoma Publications

Han D, Zager JS, Shyr Y, Chen H, Berry LD, Iyengar S, Weber JL, Marzban SS, Sondak VK, Messina JL, Vetto JT, White RL, Pockaj B, Mozzillo N,Charney KJ, Avisar E, Krouse R, Kashani-Sabet M, Leong SP. Clinicopathologic predictors of sentinel lymph node metastases in thin melanoma. J Clin Oncol. 31(35):4387-4393, 2013.

White RL, Ayers GD, Stell VH, Ding S, Gershenwald JE, Salo JC, Pockaj BA, Essner R, Faries M, Charney KJ, et al. Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol. 18:3593-3600, 2011.

Leachman SA, Carucci J, Kohlmann, Banks KC, et al. Selection criteria for genetic assessment of patients with familial melanoma. Journal of the American Academy of Dermatology 2009;61(4):677.e1-14.

Nino T, Woodhall K, Chase DR, Soeprono F. Solitary nodule in a 3 month old infant. Arch Dermatol 2008;144(3):405-410.

Leong SP, Accortt, NA, Essner R, Ross M, Gershenwald JE, Pockaj B, Hoekstra HJ, Garberoglio C, White RL, Chu DZJ, Biel M, Charney K , et al. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients for the sentinel lymph node working group. Archives Otolaryngol Head Neck Surg. 2006;132:370-373.

Goodman MM,McCullough JL. Human melanoma in cyclosporine-immunosuppressed rats. Models in Dermatology, Maiback, H.; Lowe, N. (eds), Basel, Switzerland: Karger, S., Vol. 4, 249-252, 1989.

Goodman MM, McCullough JL, Biren CA, Barr RJ. A model of human melanoma in cyclosporine-immunosuppressed rats; Journal of Investigative Dermatology 1987;88(2):141-144.